Improved natural killer cell targeting of prostate carcinoma with ATR inhibitor tuvusertib in combination with IL-15 receptor superagonist N-803 2299576
Year: 2026
Type: article
Source: The Journal of Immunology
Institutions: National Cancer Institute, ImmunityBio (United States)
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7171485822
FWCI:
Cites:
Cited by:
Related to:
